List of works - Jerzy Lukasiak

Activities of synthetic peptides against human pathogenic bacteria

scientific article published on 01 January 2004

Amphibian peptides prevent endotoxemia and bacterial translocation in bile duct-ligated rats

scientific article

Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection

scientific article

Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain

scientific article published on 2 April 2007

In vitro activities of tachyplesin III against Pseudomonas aeruginosa

scientific article published on 13 January 2007

In vitro activity and killing effect of temporin A on nosocomial isolates of Enterococcus faecalis and interactions with clinically used antibiotics.

scientific article published on 13 January 2005

In vitro activity and killing effect of the synthetic hybrid cecropin A-melittin peptide CA(1-7)M(2-9)NH(2) on methicillin-resistant nosocomial isolates of Staphylococcus aureus and interactions with clinically used antibiotics

scientific article published in July 2004

In vitro activity and killing effect of uperin 3.6 against gram-positive cocci isolated from immunocompromised patients.

scientific article published on September 2005

In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients

scientific article published in September 2005

In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi

scientific article published on 27 June 2005

In vitro activity of synthetic antimicrobial peptides against Candida

scientific article published on 01 January 2006

In vitro activity of the histatin derivative P-113 against multidrug-resistant pathogens responsible for pneumonia in immunocompromised patients

scientific article

Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis

scientific article

Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat Pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides

scientific article published on 28 July 2003

Synthesis and antimicrobial activity of truncated fragments and analogs of citropin 1.1: The solution structure of the SDS micelle-bound citropin-like peptides.

scientific article published on 16 July 2009

Temporin A as a prophylactic agent against methicillin sodium-susceptible and methicillin sodium-resistant Staphylococcus epidermidis vascular graft infection.

scientific article published in November 2002

Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models

scientific article

List of works by Jerzy Lukasiak

Activities of synthetic peptides against human pathogenic bacteria

Amphibian peptides prevent endotoxemia and bacterial translocation in bile duct-ligated rats

Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection

Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain

In vitro activities of tachyplesin III against Pseudomonas aeruginosa

In vitro activity and killing effect of temporin A on nosocomial isolates of Enterococcus faecalis and interactions with clinically used antibiotics.

In vitro activity and killing effect of the synthetic hybrid cecropin A-melittin peptide CA(1-7)M(2-9)NH(2) on methicillin-resistant nosocomial isolates of Staphylococcus aureus and interactions with clinically used antibiotics

In vitro activity and killing effect of uperin 3.6 against gram-positive cocci isolated from immunocompromised patients.

In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients

In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi

In vitro activity of synthetic antimicrobial peptides against Candida

In vitro activity of the histatin derivative P-113 against multidrug-resistant pathogens responsible for pneumonia in immunocompromised patients

Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis

Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat Pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides

Synthesis and antimicrobial activity of truncated fragments and analogs of citropin 1.1: The solution structure of the SDS micelle-bound citropin-like peptides.

Temporin A as a prophylactic agent against methicillin sodium-susceptible and methicillin sodium-resistant Staphylococcus epidermidis vascular graft infection.

Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models